Lymphoma News

gamida cell.jpg
Gamida Cell's experimental drug treatment NiCord will have Orphan Drug Status if it makes it to market. NiCord is being explo...
MD-anderson-cancer-center-logo.jpg
MD Anderson Cancer Center is in line to receive $100 million in publicly traded stock as part of a licensing agreement that i...
Adcetris
Seattle Genetics and Bristol-Myers Squibb Company have announced a clinical trial collaboration agreement that will evaluate...
chemonurse.jpg
The Connecticut Supreme Court ruled on Thursday that a 17 year old teen diagnosed with Hodgkin's lymphoma must undergo chemot...
soligenix.jpg
According to biopharmaceutical company Soligenix, the US Food and Drug Administration has fast-tracked the company's experime...
neupogen.jpeg
In a move that should lead to patients saving several hundred dollars in cancer care costs down the road, an FDA advisory com...
chemo-vials.jpg
A 17 year old Connecticut teen with Hodgkin's lymphoma has been removed from her home and is being forced to undergo chemothe...
bortezomib.jpg
The Committee for Medicinal Products for Human Use of the European Medicines Agency has given a positive opinion on the use o...
bcell-image.jpg
A retrospective study shows that autologous stem cell transplants can improve outcomes for patients whose indolent lymphoma h...
blincyto.jpg
This presentation discussed a trial in which patients with acute lymphoblastic leukemia (ALL) would benefit from a single cyc...

LymphomaInfo Social